Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study
- PMID: 31997551
- DOI: 10.1111/1744-9987.13480
Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study
Abstract
Currently, the data on independent risk factors for the progression of kidney disease in type 2 diabetes mellitus (T2DM) patients with CKD are limited. This study aimed to investigate CKD progression in T2DM patients who have reduced kidney function with baseline estimated glomerular filtration rate (eGFRs) between 15 and 59 mL/min/1.73 m2 . This study was composed of a nationwide retrospective cohort of adult T2DM patients from 831 public hospitals in Thailand during the year 2015. T2DM patients with CKD stages 3 and 4 were followed up, until development of CKD stage 5, requirement of chronic dialysis, loss to follow-up, death, or 31 May 2018, whichever came first. Cox proportional hazard regression was utilized for analysis. A total of 8464 participants were included; 30.4% were male. The mean age was 69 ± 10 years. The mean eGFR was 45 ± 11 mL/min/1.73 m2 . The incidence of CKD stage 5 or the need for chronic dialysis was 16.4 per 1000 person-years. The annual rate of eGFR decline during a mean follow-up of 29 months was -2.3 mL/min/1.73 m2 ; 14.4% had a rapid decline in eGFR. The risk factors associated with progression to CKD stage 5 or the need for chronic dialysis were diabetes duration, systolic blood pressure, serum uric acid, albuminuria, and baseline eGFR. Conversely, older age and the use of renin-angiotensin aldosterone system blockade were associated with decreased risks for rapid CKD progression and incidence CKD stage 5 or dialysis. This study identifies multiple predictive risk factors that support a multifaceted approach to prevent progression of advanced CKD.
Keywords: albuminuria; chronic kidney disease; end-stage kidney disease; glomerular filtration rate; type 2 diabetes mellitus.
© 2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
Similar articles
-
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18. Am J Kidney Dis. 2018. PMID: 29784612
-
Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.Nephrol Dial Transplant. 2020 Jan 1;35(1):115-121. doi: 10.1093/ndt/gfy211. Nephrol Dial Transplant. 2020. PMID: 30007296
-
Incidence and Risk Factors Associated with Outpatient Hypoglycemia in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Study.Endocr Res. 2020 Nov;45(4):217-225. doi: 10.1080/07435800.2020.1792921. Epub 2020 Jul 14. Endocr Res. 2020. PMID: 32662297
-
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.Nutr Metab Cardiovasc Dis. 2016 May;26(5):361-73. doi: 10.1016/j.numecd.2016.01.001. Epub 2016 Jan 13. Nutr Metab Cardiovasc Dis. 2016. PMID: 27105869 Review.
-
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.BMJ Open Diabetes Res Care. 2022 Jul;10(4):e002806. doi: 10.1136/bmjdrc-2022-002806. BMJ Open Diabetes Res Care. 2022. PMID: 35790319 Free PMC article. Review.
Cited by
-
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.Curr Hypertens Rep. 2020 Oct 31;22(12):102. doi: 10.1007/s11906-020-01116-3. Curr Hypertens Rep. 2020. PMID: 33128170 Free PMC article. Review.
-
SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease.J Clin Med. 2020 Aug 24;9(9):2723. doi: 10.3390/jcm9092723. J Clin Med. 2020. PMID: 32846935 Free PMC article.
-
Treatment Costs for Patients with Chronic Kidney Disease Who Received Multidisciplinary Care in a District Hospital in Thailand.Clinicoecon Outcomes Res. 2020 Apr 28;12:223-231. doi: 10.2147/CEOR.S253252. eCollection 2020. Clinicoecon Outcomes Res. 2020. PMID: 32425563 Free PMC article.
-
Hypertension in Adults With Diabetes in Southeast Asia: A Systematic Review.J Clin Hypertens (Greenwich). 2025 Jan;27(1):e14936. doi: 10.1111/jch.14936. Epub 2024 Nov 15. J Clin Hypertens (Greenwich). 2025. PMID: 39545715 Free PMC article.
-
A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 May 28;48(5):725-732. doi: 10.11817/j.issn.1672-7347.2023.220539. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37539575 Free PMC article. Chinese, English.
References
REFERENCES
-
- Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50.
-
- Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294-1304.
-
- Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888-1917.
-
- Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73-81.
-
- Kim KS, Park SW, Cho YW, Kim SK. Higher prevalence and progression rate of chronic kidney disease in elderly patients with type 2 diabetes mellitus. Diabetes Metab J. 2018;42(3):224-232.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous